Very Severe COPD –
Outcomes and Cost Effectiveness of a Respiratory Coordinated Care Program in Patients with Severe or Very Severe COPD
... more severe COPD as the potential to reduce hospitalization is ...with severe and very severe ...of COPD, hospital admissions for non respiratory illnesses may also have been of ...
7
Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
... stable COPD, the goals for treatment include the reduction of symptoms (symptom relief, improvement in health status, and exercise tolerance) and the reduction of risk, through the prevention of disease ...
9
Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD
... and COPD are chronic respiratory diseases characterized by evident respiratory symptoms, progressive loss of lung function, and the degeneration of functional ...with severe to very severe ...
8
Cost-effectiveness analysis of roflumilast/ tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD
... higher COPD-related costs, but this effect on costs would also be mitigated by lower drug costs from ...for very severe COPD patients was based on published data from the M2-124/125 trials ...
12
Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
... to very severe COPD, mean responses to a near-maximal bronchodilator chal- lenge decline progressively over time to a statistically significant, albeit modest and highly variable, extent, ir- ...
10
Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPD
... Our results demonstrate that the magnitude of a potential learning effect is less dominant and prevalent in patients with severe and very severe COPD, especially in those with low initial ...
11
Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey
... Dovepress solem et al our patients fell into quadrant D, which would be expected given the original cohort-selection criteria: patients were required to have been diagnosed with severe or very severe ...
8
Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model
... Methods: A Markov model was developed to estimate the costs and outcomes associated with UMEC/VI treatment in patients with moderate to very severe COPD (GSK study number: HO-13-13411). Clinical ...
12
Can early introduction of specialized palliative care limit intensive care, emergency and hospital admissions in patients with severe and very severe COPD? a randomized study
... severe COPD? a randomized study Catherine Weber 1* , Jerome Stirnemann 2 , François R Herrmann 2 , Sophie Pautex 1 and Jean- Paul Janssens 3 Abstract Background: COPD is a progressive lung disorder ...
7
<p>Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial</p>
... including COPD. 13 The mechanism of ginseng relating to the treatment of COPD may include anti – in fl ammatory and antioxidant effects of its constituent compounds, the ...to very severe ...
10
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
... moderate-to-very severe COPD, based on improvement in lung function and health status, as well as reduction in COPD ...tolerated. Very low rates of pneumonia occurred in all treatment ...
15
Effect of background long-acting beta<sub>2</sub>-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
... of COPD therapies may help clinicians to make informed decisions when tailoring a patient’s ...moderate-to-very severe COPD, in order to be representative of the general COPD ...
13
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
... in COPD, with smaller relative and absolute increases in FEV 1 as GOLD severity ...more severe COPD 18 and points toward the importance of lung volume change, rather than spirometry in these ...
13
<p>A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD</p>
... To our knowledge, this study represents one of the largest and most detailed databases of Holter ECG data in COPD— involving 775 patients—and benefits from the availability of baseline and follow-up data for ...
11
Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK
... This analysis is the first to assess exacerbation rates and cost-effectiveness specifically in a patient population receiv- ing roflumilast in addition to triple inhaled therapy. Although no statistically significant ...
14
<p>Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD</p>
... olodaterol has been shown to have no adverse effects on HR or BP. 24,25 In the present study, combination tiotropium/olo- daterol therapy had little or no clinically meaningful effect on HR or BP when compared with ...
10
Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
... to very severe COPD taking once-daily inhaled revefenacin at doses of 175 μg and 88 μg, with or without concomi- tant LABA/ICS therapy ...to very severe ...
10
A prospective assessment study of thyroid dysfunction in moderate to severe COPD
... with very severe COPD, there are no established guidelines for pulmonary rehabilitation programmes, but carefully supervised exercise condition in the hospital setting , with oxygen supplementation ...
112
Anxiety and dyspnea for patients with severe COPD
... ikke fikk nok luft, følte seg som en byrde for familien og streben etter følelsen av velvære Forfattern es bakgrunn oppgitt 3 Cooney, Mee, Casey, Murphy, Kirwan, Bruke, Co[r] ...
76
<p>Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD</p>
... have COPD and concomitant asthma with a prevalence ranging from ...with COPD based on symptoms such as wheezing, paroxysmal dyspnea, and airway rever- ...with COPD present with eosinophilic airway in ...
9